Epidemiology


Etiology


  • Viral: Most common cause (~70-90%). Adenovirus, Rhinovirus, Coronavirus, EBV (Mononucleosis), CMV, HSV.
  • Bacterial: Group A -hemolytic Streptococcus (GAS/S. pyogenes) is the most important bacterial cause (15-30% in children). t
  • Other Bacterial: Fusobacterium necrophorum (Lemierre syndrome), N. gonorrhoeae, C. diphtheriae (rare/unvaccinated).

Pathophysiology


Clinical features


Acute bacterial tonsillopharyngitis

  • Sudden onset of symptoms: fever, sore throat, dysphagia
  • Significantly inflamed pharynx
    • Pharyngeal and/or tonsillar erythema and edema
    • Pharyngeal and/or tonsillar exudates (rare in children < 3 years of age)
    • Palatal petechiae
  • Cervical lymphadenitis
  • Absence of cough

Acute viral tonsillopharyngitis

Accompanied by symptoms of a common cold (rhinitis and/or pharyngitis)

Diagnostics


  • Initial / Screening TestRapid Antigen Detection Test (RADT) for GAS. c
    • High specificity (>95%), moderate sensitivity (70–90%).
    • Rapid results (minutes).
  • Confirmatory / Gold StandardThroat Culture.
    • Mandatory in children/adolescents if RADT is negative (to prevent ARF). c
    • Not routinely required in adults if RADT is negative due to low risk of ARF.
  • Key Labs:
    • Heterophile antibody test (Monospot) / EBV serologies if infectious mononucleosis suspected.
    • Antistreptolysin O (ASO) titer
      • Elevated levels suggest a previous GAS infection; not helpful to diagnose acute pharyngitis
      • Indicated in the workup of nonsuppurative complications of GAS tonsillopharyngitis (e.g., acute rheumatic fever, PSGN).

Treatment


Complications

Infectious thrombophlebitis of the internal jugular vein (Lemierre syndrome)

  • EtiologyFusobacterium necrophorum (anaerobic GNR) following pharyngitis, dental infection, or tonsillitis in young, healthy pts (age 15–24). c
  • Clinical Presentation:
    • Oropharyngeal infection: Preceding sore throat/tonsillitis -> high fevers, rigors.
    • Neck findingsSCM tenderness and induration along the internal jugular vein (IJV). c
    • Septic pulmonary emboli: Dyspnea, pleuritic CP, hemoptysis, nodular lung lesions.
  • Diagnosis:
    • CT neck w/ IV contrastBest initial test (shows IJV thrombosis, parapharyngeal swelling).
    • CXR / CT chest: Bilateral nodular opacities, cavitary lesions, pleural effusions.
    • Blood cultures: Confirmatory for F. necrophorum.
  • Management:
    • IV Abx: Empiric anaerobic coverage w/ Ampicillin-sulbactam OR Ceftriaxone + Metronidazole (3–6 wks).
    • AnticoagulationNOT routine (reserved for thrombus progression/persistent emboli despite 48–72h of Abx).
    • Drainage: For persistent deep neck abscesses or empyema.
  • Key Distractors:
    • Peritonsillar abscess: Uvula deviation, trismus, “hot potato” voice; no IJV thrombosis or lung emboli.
    • Tricuspid endocarditis: IVDU history, holosystolic murmur; no preceding neck pain/IJV clot.